Andreas Kling

This inventor holds 73 USPTO granted patents and 20 published patent applications, plus 2 CIPO patents and 13 EPO patents, primarily in Oxindole Compounds (CPC class C07D). Top assignees: Abbott Gmbh & Co Kg, Abbvie Deutschland Gmbh and Co Kg, Basf Aktiengesellschaft. Active years: 1997-2018.

USPTO Granted Patents = 73 (Patent Applications = 20)

% Patents Active = 49.3

CIPO Patents = 2 (Patent Applications = 11)

EPO Patents = 13 (Patent Applications = 23)

Average Co-Inventor Count = 7.9

ph-index = 10

Forward Citations = 409(Granted Patents)

Forward Citations (Not Self Cited) = 321(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Manneim, DE (2008 - 2013)
Mannheim, DE (1997 - 2017)
Wiesbaden, DE (2015 - 2017)
Ludwigshafen, DE (2010 - 2018)

Company Filing History:

Abbvie Deutschland Gmbh and Co Kg

patents

17 out of 10,754

Basf Aktiengesellschaft

Abbott Laboratories Corporation

patents

6. 1 out of 5

Basf Aktienegesellschaft

patents

7. 1 out of 834,307

Other

patents

where one patent can have more than one assignee

Years Active: 1997-2018

Loading Chart...

Areas of Expertise:

Oxindole Derivatives

Carboxamide Compounds

Guanidine Compounds

Calpain Inhibitors

5-HT5 Receptors

Antineoplastic Peptides

Aminotetraline Derivatives

Fused Heterocyclic Compounds

Nitrogen-Bound Spiro Substituents

Cycloaliphatic Radicals

Vasopressin-Related Diseases

Oxetane Substituents

73 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9862704 - Oxindole derivatives carrying an amine-substituted piperidyl-acetidinyl substituent and use thereof for treating vasopressine-related diseases (2018-01-09),

2. 9840495 - Oxindole derivatives carrying a piperidyl-substituted azetidinyl substituent and use thereof for treating vasopressine-related diseases (2017-12-12),

3. 9688678 - Oxindole compounds carrying a nitrogen-bound spiro substituent and use thereof for treating vasopressin-related diseases (2017-06-27),

4. 9657002 - Oxindole derivatives carrying an oxetane substituent and use thereof for treating vassopressin-related diseases (2017-05-23),

5. 9617226 - Fused heterocyclic or carbocyclic compounds carrying a substituted cycloaliphatic radical and use thereof for treating vasopressin-related diseases (2017-04-11),

6. 9567325 - Carboxamide compounds and their use as calpain inhibitors (2017-02-14),

7. 9527856 - Oxindole compounds carrying a CO-bound spiro substituent and use thereof for treating vasopressin-related diseases (2016-12-27),

8. 9527811 - Carboxamide compounds and their use as calpain inhibitors (2016-12-27),

9. 9475782 - Guanidine compounds, and use thereof as binding partners for 5-HT5 receptors (2016-10-25),

10. 9296697 - [object Object] (2016-03-29),

11. 9273036 - Oxindole derivatives carrying an oxetane substituent and use thereof for treating vasopressine-related diseases (2016-03-01),

12. 9150553 - Carboxamide compounds and their use as calpain inhibitors (2015-10-06),

13. 9150545 - Carboxamide compounds and their use as calpain inhibitors V (2015-10-06),

14. 9139557 - Carboxamide compounds and their use as calpain inhibitors (2015-09-22),

15. 9096619 - Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy (2015-08-04),

Title: The Innovative Journey of Andreas Kling

Introduction: Andreas Kling, a visionary inventor hailing from Mannheim, Germany, has made significant contributions to the world of technology through his groundbreaking inventions and patents.

Latest Patents: Andreas Kling's latest patents include a cutting-edge software application for optimizing energy consumption in industrial settings and a revolutionary medical device for non-invasive monitoring of vital signs.

Career Highlights: With a career spanning over two decades, Andreas Kling has established himself as a leading figure in the field of innovation. He has worked with top research institutions and universities to develop cutting-edge technologies that have transformed various industries.

Collaborations: Throughout his career, Andreas Kling has collaborated with renowned companies, such as tech giants and leading medical device manufacturers, to bring his inventions to the market. His ability to bridge the gap between academia and industry has led to the successful commercialization of several groundbreaking technologies.

Conclusion: Andreas Kling's passion for innovation and his relentless pursuit of excellence have cemented his reputation as a prolific inventor in the global technology landscape. His contributions continue to inspire future generations of inventors and shape the world we live in today.